HEADER TRANSLATION 22-NOV-01 1GQE TITLE POLYPEPTIDE CHAIN RELEASE FACTOR 2 (RF2) FROM ESCHERICHIA TITLE 2 COLI COMPND MOL_ID: 1; COMPND 2 MOLECULE: RELEASE FACTOR 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RF2; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12 KEYWDS PROTEIN SYNTHESIS, RIBOSOME, MACROMOLECULAR MIMICRY, KEYWDS 2 TRANSLATION EXPDTA X-RAY DIFFRACTION AUTHOR B.VESTERGAARD,M.KJELDGAARD REVDAT 3 02-JUN-09 1GQE 1 HEADER DBREF SEQADV REVDAT 2 24-FEB-09 1GQE 1 VERSN REVDAT 1 04-APR-02 1GQE 0 JRNL AUTH B.VESTERGAARD,L.VAN,G.ANDERSEN,J.NYBORG, JRNL AUTH 2 R.BUCKINGHAM,M.KJELDGAARD JRNL TITL BACTERIAL POLYPEPTIDE RELEASE FACTOR RF2 IS JRNL TITL 2 STRUCTURALLY DISTINCT FROM EUKARYOTIC ERF1. JRNL REF MOL.CELL V. 8 1375 2001 JRNL REFN ISSN 1097-2765 JRNL PMID 11779511 JRNL DOI 10.1016/S1097-2765(01)00415-4 REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1828329.04 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 30515 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1517 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.4 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4116 REMARK 3 BIN R VALUE (WORKING SET) : 0.278 REMARK 3 BIN FREE R VALUE : 0.310 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.6 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 243 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2802 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 286 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.1 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.8 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.36 REMARK 3 B22 (A**2) : -3.52 REMARK 3 B33 (A**2) : 0.16 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 3.64 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.1 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.2 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.67 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.68 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.77 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.34 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.61 ; 2.50 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.395009 REMARK 3 BSOL : 51.2865 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT RESTRAINED BY SAD PHASES REMARK 3 REGION 247 - 257 WAS NOT VISIBLE IN THE ELECTRON DENSITY, BUT REMARK 3 WAS MODELLED STEREOCHEMICALLY ACCORDING TO STRUCTURAL REMARK 3 SIMILARITY WITH THE GGR MOTIF IN RIBOSOMAL PROTEIN S5 (1FJF) REMARK 3 AND THE GGQ MOTIF IN ERF1 (1DT9) REMARK 4 REMARK 4 1GQE COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-NOV-01. REMARK 100 THE PDBE ID CODE IS EBI-9018. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59537 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.154 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40 MM TRISHCL, PH 7.6, REMARK 280 400 MM NACL, 40 MM MGCL2, 2% ETHYLENE GLYCOL REMARK 280 20 MM DTT, PEG 2K MME 28-34% REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.94650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED MUTATION: THR(246)ALA. RESIDUE 298 CORRESPONDS TO A REMARK 400 LEUCINE IN THE SWISS-PROT SEQUENCE, BUT IS CLEARLY IDENTIFIED REMARK 400 AS A VALINE IN ELECTRON DENSITY. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 PHE A 2 REMARK 465 GLU A 3 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY) REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES; REMARK 475 C=CHAIN IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 SER A 247 REMARK 475 GLY A 248 REMARK 475 ALA A 249 REMARK 475 GLY A 250 REMARK 475 GLY A 251 REMARK 475 GLN A 252 REMARK 475 HIS A 253 REMARK 475 VAL A 254 REMARK 475 ASN A 255 REMARK 475 ARG A 256 REMARK 475 THR A 257 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 45 0.62 -66.41 REMARK 500 ASP A 228 -21.77 82.15 REMARK 500 ALA A 246 -136.47 -90.31 REMARK 500 GLN A 252 21.46 -145.95 REMARK 500 HIS A 253 -85.71 -64.88 REMARK 500 GLU A 258 -57.27 62.01 REMARK 500 SER A 259 17.62 95.31 REMARK 500 MSE A 310 -78.69 -129.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 999 REMARK 999 SEQUENCE REMARK 999 CRYSTALS FROM MUTANT T246A. RESIDUE 298 CORRESPONDS TO A REMARK 999 LEUCINE IN THE SWISS-PROT SEQUENCE, BUT IS CLEARLY IDENTIFIED REMARK 999 AS A VALINE IN ELECTRON DENSITY. DBREF 1GQE A 1 365 UNP P07012 RF2_ECOLI 1 365 SEQADV 1GQE ALA A 246 UNP P07012 THR 246 ENGINEERED MUTATION SEQADV 1GQE VAL A 298 UNP P07012 LEU 298 CONFLICT SEQRES 1 A 365 MSE PHE GLU ILE ASN PRO VAL ASN ASN ARG ILE GLN ASP SEQRES 2 A 365 LEU THR GLU ARG SER ASP VAL LEU ARG GLY TYR LEU ASP SEQRES 3 A 365 TYR ASP ALA LYS LYS GLU ARG LEU GLU GLU VAL ASN ALA SEQRES 4 A 365 GLU LEU GLU GLN PRO ASP VAL TRP ASN GLU PRO GLU ARG SEQRES 5 A 365 ALA GLN ALA LEU GLY LYS GLU ARG SER SER LEU GLU ALA SEQRES 6 A 365 VAL VAL ASP THR LEU ASP GLN MSE LYS GLN GLY LEU GLU SEQRES 7 A 365 ASP VAL SER GLY LEU LEU GLU LEU ALA VAL GLU ALA ASP SEQRES 8 A 365 ASP GLU GLU THR PHE ASN GLU ALA VAL ALA GLU LEU ASP SEQRES 9 A 365 ALA LEU GLU GLU LYS LEU ALA GLN LEU GLU PHE ARG ARG SEQRES 10 A 365 MSE PHE SER GLY GLU TYR ASP SER ALA ASP CYS TYR LEU SEQRES 11 A 365 ASP ILE GLN ALA GLY SER GLY GLY THR GLU ALA GLN ASP SEQRES 12 A 365 TRP ALA SER MSE LEU GLU ARG MSE TYR LEU ARG TRP ALA SEQRES 13 A 365 GLU SER ARG GLY PHE LYS THR GLU ILE ILE GLU GLU SER SEQRES 14 A 365 GLU GLY GLU VAL ALA GLY ILE LYS SER VAL THR ILE LYS SEQRES 15 A 365 ILE SER GLY ASP TYR ALA TYR GLY TRP LEU ARG THR GLU SEQRES 16 A 365 THR GLY VAL HIS ARG LEU VAL ARG LYS SER PRO PHE ASP SEQRES 17 A 365 SER GLY GLY ARG ARG HIS THR SER PHE SER SER ALA PHE SEQRES 18 A 365 VAL TYR PRO GLU VAL ASP ASP ASP ILE ASP ILE GLU ILE SEQRES 19 A 365 ASN PRO ALA ASP LEU ARG ILE ASP VAL TYR ARG ALA SER SEQRES 20 A 365 GLY ALA GLY GLY GLN HIS VAL ASN ARG THR GLU SER ALA SEQRES 21 A 365 VAL ARG ILE THR HIS ILE PRO THR GLY ILE VAL THR GLN SEQRES 22 A 365 CYS GLN ASN ASP ARG SER GLN HIS LYS ASN LYS ASP GLN SEQRES 23 A 365 ALA MSE LYS GLN MSE LYS ALA LYS LEU TYR GLU VAL GLU SEQRES 24 A 365 MSE GLN LYS LYS ASN ALA GLU LYS GLN ALA MSE GLU ASP SEQRES 25 A 365 ASN LYS SER ASP ILE GLY TRP GLY SER GLN ILE ARG SER SEQRES 26 A 365 TYR VAL LEU ASP ASP SER ARG ILE LYS ASP LEU ARG THR SEQRES 27 A 365 GLY VAL GLU THR ARG ASN THR GLN ALA VAL LEU ASP GLY SEQRES 28 A 365 SER LEU ASP GLN PHE ILE GLU ALA SER LEU LYS ALA GLY SEQRES 29 A 365 LEU MODRES 1GQE MSE A 73 MET SELENOMETHIONINE MODRES 1GQE MSE A 118 MET SELENOMETHIONINE MODRES 1GQE MSE A 147 MET SELENOMETHIONINE MODRES 1GQE MSE A 151 MET SELENOMETHIONINE MODRES 1GQE MSE A 288 MET SELENOMETHIONINE MODRES 1GQE MSE A 291 MET SELENOMETHIONINE MODRES 1GQE MSE A 300 MET SELENOMETHIONINE MODRES 1GQE MSE A 310 MET SELENOMETHIONINE HET MSE A 73 8 HET MSE A 118 8 HET MSE A 147 8 HET MSE A 151 8 HET MSE A 288 8 HET MSE A 291 8 HET MSE A 300 8 HET MSE A 310 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 2 HOH *286(H2 O1) HELIX 1 1 ASN A 5 LEU A 25 1 21 HELIX 2 2 ASP A 26 GLN A 43 1 18 HELIX 3 3 PRO A 44 ASN A 48 5 5 HELIX 4 4 GLU A 49 ASP A 91 1 43 HELIX 5 5 ASP A 92 GLU A 114 1 23 HELIX 6 6 PHE A 115 PHE A 119 5 5 HELIX 7 7 GLY A 137 ARG A 159 1 23 HELIX 8 8 TYR A 187 ARG A 193 1 7 HELIX 9 9 THR A 194 THR A 196 5 3 HELIX 10 10 ASN A 235 ALA A 237 5 3 HELIX 11 11 SER A 279 LYS A 307 1 29 HELIX 12 12 ASP A 329 SER A 331 5 3 HELIX 13 13 ASN A 344 ASP A 350 1 7 HELIX 14 14 LEU A 353 ALA A 363 1 11 SHEET 1 AA 8 LYS A 162 GLU A 170 0 SHEET 2 AA 8 ILE A 176 SER A 184 -1 N LYS A 177 O SER A 169 SHEET 3 AA 8 CYS A 128 ALA A 134 -1 O CYS A 128 N ILE A 183 SHEET 4 AA 8 ARG A 213 PRO A 224 -1 O SER A 219 N GLN A 133 SHEET 5 AA 8 GLY A 197 LYS A 204 -1 O GLY A 197 N ALA A 220 SHEET 6 AA 8 GLN A 322 VAL A 327 1 N ILE A 323 O VAL A 198 SHEET 7 AA 8 ARG A 332 ASP A 335 -1 O ARG A 332 N VAL A 327 SHEET 8 AA 8 GLU A 341 THR A 342 -1 O THR A 342 N ILE A 333 SHEET 1 AB 3 LEU A 239 TYR A 244 0 SHEET 2 AB 3 ALA A 260 HIS A 265 -1 O ALA A 260 N TYR A 244 SHEET 3 AB 3 VAL A 271 CYS A 274 -1 O THR A 272 N ILE A 263 LINK C GLN A 72 N MSE A 73 1555 1555 1.33 LINK C MSE A 73 N LYS A 74 1555 1555 1.33 LINK C ARG A 117 N MSE A 118 1555 1555 1.33 LINK C MSE A 118 N PHE A 119 1555 1555 1.33 LINK C SER A 146 N MSE A 147 1555 1555 1.33 LINK C MSE A 147 N LEU A 148 1555 1555 1.33 LINK C ARG A 150 N MSE A 151 1555 1555 1.33 LINK C MSE A 151 N TYR A 152 1555 1555 1.33 LINK C ALA A 287 N MSE A 288 1555 1555 1.33 LINK C MSE A 288 N LYS A 289 1555 1555 1.33 LINK C GLN A 290 N MSE A 291 1555 1555 1.33 LINK C MSE A 291 N LYS A 292 1555 1555 1.33 LINK C GLU A 299 N MSE A 300 1555 1555 1.33 LINK C MSE A 300 N GLN A 301 1555 1555 1.33 LINK C ALA A 309 N MSE A 310 1555 1555 1.33 LINK C MSE A 310 N GLU A 311 1555 1555 1.33 CRYST1 57.388 49.893 63.144 90.00 107.01 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017425 0.000000 0.005331 0.00000 SCALE2 0.000000 0.020043 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016561 0.00000